Patents by Inventor Tim Conze

Tim Conze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150045541
    Abstract: Monoclonal antibodies, or fragments thereof, are used for isolating and/or identifying at least one cell population. The cell population can include any of the following types of cells: haematopoietic stem cells, neuronal stem cells, neuronal progenitor cells, mesenchymal stem cells and mesenchymal progenitor cells. The antibodies, or fragments thereof, bind to an antigen which is the same as that bound by an antibody which is produced by the hybridoma cell lines CUB1, CUB2, CUB3 and CUB4, which were deposited in the DSMZ under the numbers DSM ACC2569, DSM ACC2566 and DSM ACC2565, on Aug. 14, 2002, and DSM ACC2551, on Jul. 7, 2002.
    Type: Application
    Filed: September 19, 2014
    Publication date: February 12, 2015
    Inventors: HANS-JOERG BUEHRING, REINER LAMMERS, SELIM KUCI, TIM CONZE
  • Publication number: 20130267687
    Abstract: Monoclonal antibodies, or fragments thereof, are used for isolating and/or identifying at least one cell population. The cell population can include any of the following types of cells: haematopoietic stem cells, neuronal stem cells, neuronal progenitor cells, mesenchymal stem cells and mesenchymal progenitor cells. The antibodies, or fragments thereof, bind to an antigen which is the same as that bound by an antibody which is produced by the hybridoma cell lines CUB1, CUB2, CUB3 and CUB4, which were deposited in the DSMZ under the numbers DSM ACC2569, DSM ACC2566 and DSM ACC2565, on Aug. 14, 2002, and DSM ACC2551, on Jul. 12, 2002.
    Type: Application
    Filed: April 23, 2013
    Publication date: October 10, 2013
    Applicant: HOFFMAN-LA ROCHE INC.
    Inventors: HANS-JOERG BUEHRING, REINER LAMMERS, SELIM KUCI, TIM CONZE
  • Publication number: 20100179306
    Abstract: Monoclonal antibodies, or fragments thereof, are used for isolating and/or identifying at least one cell population. The cell population can include any of the following types of cells: haematopoietic stem cells, neuronal stem cells, neuronal progenitor cells, mesenchymal stem cells and mesenchymal progenitor cells. The antibodies, or fragments thereof, bind to an antigen which is the same as that bound by an antibody which is produced by the hybridoma cell lines CUB1, CUB2, CUB3 and CUB4, which were deposited in the DSMZ under the numbers DSM ACC2569, DSM ACC2566 and DSM ACC2565, on 14 Aug. 2002, and DSM ACC2551, on 12 Jul. 2002.
    Type: Application
    Filed: January 13, 2010
    Publication date: July 15, 2010
    Applicant: HOFFMAN-LA ROCHE INC.
    Inventors: Hans-Joerg BUEHRING, Reiner LAMMERS, Selim KUCI, Tim CONZE
  • Patent number: 7741114
    Abstract: Monoclonal antibodies, or fragments thereof, are used for isolating and/or identifying at least one cell population. The cell population can include any of the following types of cells: haematopoietic stem cells, neuronal stem cells, neuronal progenitor cells, mesenchymal stem cells and mesenchymal progenitor cells. The antibodies, or fragments thereof, bind to an antigen which is the same as that bound by an antibody which is produced by the hybridoma cell lines CUB1, CUB2, CUB3 and CUB4, which were deposited in the DSMZ under the numbers DSM ACC2569, DSM ACC2566 and DSM ACC2565, on 14 Aug. 2002, and DSM ACC2551, on 12 Jul. 2002.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: June 22, 2010
    Assignee: Hoffmann-La Roche, Inc.
    Inventors: Hans-Joerg Buehring, Reiner Lammers, Selim Kuci, Tim Conze
  • Publication number: 20090181033
    Abstract: Monoclonal antibodies, or fragments thereof, are used for isolating and/or identifying at least one cell population. The cell population can include any of the following types of cells: haematopoietic stem cells, neuronal stem cells, neuronal progenitor cells, mesenchymal stem cells and mesenchymal progenitor cells. The antibodies, or fragments thereof, bind to an antigen which is the same as that bound by an antibody which is produced by the hybridoma cell lines CUB1, CUB2, CUB3 and CUB4, which were deposited in the DSMZ under the numbers DSM ACC2569, DSM ACC2566 and DSM ACC2565, on Aug. 14, 2002, and DSM ACC2551, on Jul. 12, 2002.
    Type: Application
    Filed: March 10, 2009
    Publication date: July 16, 2009
    Applicant: HOFFMAN-LA ROCHE INC.
    Inventors: HANS-JOERG BUEHRING, REINER LAMMERS, SELIM KUCI, TIM CONZE
  • Patent number: 7541030
    Abstract: The invention relates to monoclonal antibodies, or fragments thereof, for isolating and/or identifying at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal progenitor cells, mesenchymal stem cells and mesenchymal progenitor cells. The antibodies, or fragments thereof, bind to an antigen which is the same as that bound by an antibody which is produced by the hybridoma cell lines CUB1, CUB2, CUB3 and CUB4, which were deposited in the DSMZ under the numbers DSM ACC2569, DSM ACC2566 and DSM ACC2565, on Aug, 14, 2002, and DSM ACC2551, on Dec. 7, 2002.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: June 2, 2009
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Hans-Joerg Buehring, Reiner Lammers, Selim Kuci, Tim Conze
  • Publication number: 20040053343
    Abstract: The invention relates to monoclonal antibodies, or fragments thereof, for isolating and/or identifying at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal progenitor cells, mesenchymal stem cells and mesenchymal progenitor cells. The antibodies, or fragments thereof, bind to an antigen which is the same as that bound by an antibody which is produced by the hybridoma cell lines CUB1, CUB2, CUB3 and CUB4, which were deposited in the DSMZ under the numbers DSM ACC2569, DSM ACC2566 and DSM ACC2565, on 14.08.2002, and DSM ACC2551, on 12.07.2002.
    Type: Application
    Filed: July 25, 2003
    Publication date: March 18, 2004
    Inventors: Hans-Joerg Buehring, Reiner Lammers, Selim Kuci, Tim Conze